ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2019 | $1,000 | -66.7% | 1,468 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 1,468 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 1,468 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | -16.7% | 1,468 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | 0.0% | 1,468 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | -25.0% | 1,468 | -6.4% | 0.00% | – |
| Q3 2017 | $8,000 | -95.5% | 1,568 | -95.4% | 0.00% | -100.0% |
| Q2 2017 | $179,000 | +2883.3% | 34,433 | +2245.6% | 0.01% | – |
| Q1 2017 | $6,000 | +20.0% | 1,468 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -37.5% | 1,468 | -40.5% | 0.00% | – |
| Q3 2016 | $8,000 | +100.0% | 2,468 | +68.1% | 0.00% | – |
| Q2 2016 | $4,000 | – | 1,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
| DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
| BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
| SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
| Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
| SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
| Geduld E E | 25,000 | $160,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |